Objective. The metastatic process in epithelial ovarian cancer is thought t
o involve surface shedding and subsequent dissemination of ovarian cancer c
ells, facilitated by localized proteolysis at the interface between ovarian
cancer cells and peritoneal surfaces. The factors regulating the metastati
c process, however, are not well understood. Transforming growth factor-bet
a (TGF-beta) is a multifunctional peptide that elicits numerous cellular ef
fects pertinent to the metastatic process. The purpose of this study was to
evaluate the regulatory role of TGF-beta on metastasis in ovarian cancer.
Methods. We evaluated the effect of TGF-beta on the metastatic characterist
ics (adhesion, invasion, motility, proteolysis) of five ovarian cancer cell
lines (DOV-13 and OVCA 420, 429, 432, and 433), two short-term primary ova
rian cancer cell cultures (OVCA 10 and OVCA 208), and five normal ovarian s
urface epithelial (NOSE) cell cultures (OSE 133, 185, 186, 188, and 189). T
he effect of TGF-beta on invasion and proteolysis was quantified using a mo
dified Boyden chamber invasion assay, zymography, a coupled colorimetric ac
tivity assay, and an HPLC-based quantitation of synthetic substrate cleavag
e.
Results. TGF-beta significantly increased invasion in five of seven ovarian
cancer cell lines in amounts ranging from 2- to 20-fold. In contrast, TGF-
beta significantly decreased invasion in two of five NOSE isolates by 50 to
80% and had no significant effect on invasion in three, TGF-beta treatment
increased matrix metalloproteinase (MMP) expression in OVCA 420 and 433 an
d DOV-13, resulting in MMP-dependent collagen cleavage and invasive activit
y. Addition of the MMP inhibitor GI12947 neutralized the enhancing effect o
f TGF-beta on invasion. TGF-beta had no effect on ovarian cancer cell motil
ity and only increased adhesion in DOV-13.
Conclusions. These data suggest that TGF-beta may enhance the invasiveness
of ovarian cancers through induction of MMP activity. (C) 2001 Academic Pre
ss.